Cardinal Partners is a venture capital company specialising in early/growth-stage financing rounds for entrepreneurs operating in the healthcare and life sciences sector.
Cardinal Partners invests in healthcare technology-enabled services and life sciences companies.
Cardinal Partners is a venture capital company specialising in early/growth-stage financing rounds for entrepreneurs operating in the healthcare and life sciences sector.
Cardinal Partners is a Princeton-based venture capital company founded in 1996 by John Clarke, Thomas McKinley, and Kent Marquardt. As early/growth-stage investors, Cardinal Partners works with scientists, consultants, and entrepreneurs in the field of life sciences, technology-enabled services, and healthcare IT.
Cardinal Partners' most recent investment was on Apr 30, 2019, when Vividion Therapeutics raised $82M.